• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌免疫逃逸的新型分子机制:NSUN2介导的SOAT2 RNA甲基化增加

Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation.

作者信息

Jiang Jinhua, Liu Feng, Cui Dan, Xu Caixia, Chi Jiachang, Yan Tinghua, Guo Fang

机构信息

Department of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, P. R. China.

Key Laboratory of Systems Biomedicine, Ministry of Education, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, P. R. China.

出版信息

Cancer Commun (Lond). 2025 Apr 14. doi: 10.1002/cac2.70023.

DOI:10.1002/cac2.70023
PMID:40227950
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is a deadly malignancy known for its ability to evade immune surveillance. NOP2/Sun RNA methyltransferase family member 2 (NSUN2), an RNA methyltransferase involved in carcinogenesis, has been associated with immune evasion and energy metabolism reprogramming. This study aimed to examine the molecular mechanisms underlying the involvement of NSUN2 in immune evasion and metabolic reprogramming of HCC.

METHODS

Single-cell transcriptomic sequencing was applied to examine cellular composition changes, particularly immune cell dynamics, in HCC and adjacent normal tissues. Bulk RNA-seq and proteomics identified key genes and proteins. Methylation sequencing and methylated RNA immunoprecipitation (MeRIP) were carried out to characterize the role of NSUN2 in 5-methylcytosine (m5C) modification of sterol O-acyltransferase 2 (SOAT2). Clinical samples from 30 HCC patients were analyzed using reverse transcription-quantitative polymerase chain reaction and Western blotting. Gene expression was manipulated using CRISPR/Cas9 and lentiviral vectors. In vitro co-culture models and metabolomics were used to study HCC cell-T cell interactions, energy metabolism, and immune evasion. Tumor growth in an orthotopic mouse model was monitored by bioluminescence imaging, with subsequent measurements of tumor weight, volume, and immunohistochemical staining.

RESULTS

Single-cell transcriptomic analysis identified a marked increase in malignant cells in HCC tissues. Cell communication analysis indicated that tumor cells might promote cancer progression by evading immune clearance. Multi-omics analyses identified NSUN2 as a key regulator in HCC development. MeRIP confirmed that NSUN2 facilitated the m5C modification of SOAT2. Analysis of human HCC tissue samples demonstrated pronounced upregulation of NSUN2 and SOAT2, along with elevated m5C levels in HCC tissues. In vitro experiments uncovered that NSUN2 augmented the reprogramming of energy metabolism and repressed the activity and cytotoxicity of CD8 T cells, contributing to immune evasion. In vivo studies further substantiated the role of NSUN2 in fostering immune evasion and tumor formation of HCC by modulating the m5C modification of SOAT2.

CONCLUSIONS

The findings highlight the critical role of NSUN2 in driving HCC progression through the regulation of m5C modification on SOAT2. These findings present potential molecular markers for HCC diagnosis and therapeutic targets for its treatment.

摘要

背景

肝细胞癌(HCC)是一种致命的恶性肿瘤,以其逃避免疫监视的能力而闻名。NOP2/Sun RNA甲基转移酶家族成员2(NSUN2)是一种参与致癌作用的RNA甲基转移酶,与免疫逃逸和能量代谢重编程有关。本研究旨在探讨NSUN2参与HCC免疫逃逸和代谢重编程的分子机制。

方法

应用单细胞转录组测序来检测HCC组织和相邻正常组织中的细胞组成变化,特别是免疫细胞动态。批量RNA测序和蛋白质组学鉴定关键基因和蛋白质。进行甲基化测序和甲基化RNA免疫沉淀(MeRIP)以表征NSUN2在固醇O-酰基转移酶2(SOAT2)的5-甲基胞嘧啶(m5C)修饰中的作用。使用逆转录定量聚合酶链反应和蛋白质印迹法分析30例HCC患者的临床样本。使用CRISPR/Cas9和慢病毒载体来调控基因表达。体外共培养模型和代谢组学用于研究HCC细胞与T细胞的相互作用、能量代谢和免疫逃逸。通过生物发光成像监测原位小鼠模型中的肿瘤生长,随后测量肿瘤重量及其体积,并进行免疫组织化学染色。

结果

单细胞转录组分析确定HCC组织中恶性细胞显著增加。细胞通讯分析表明肿瘤细胞可能通过逃避免疫清除来促进癌症进展。多组学分析确定NSUN2是HCC发展中的关键调节因子。MeRIP证实NSUN2促进了SOAT2的m5C修饰。对人HCC组织样本的分析表明,HCC组织中NSUN2和SOAT2明显上调,同时m5C水平升高。体外实验发现,NSUN2增强了能量代谢重编程,并抑制了CD8 T细胞的活性和细胞毒性,从而导致免疫逃逸。体内研究进一步证实了NSUN2通过调节SOAT2的m5C修饰在促进HCC免疫逃逸和肿瘤形成中的作用。

结论

这些发现突出了NSUN2通过调节SOAT2的m5C修饰在推动HCC进展中的关键作用。这些发现为HCC诊断提供了潜在的分子标志物,并为其治疗提供了治疗靶点。

相似文献

1
Novel molecular mechanisms of immune evasion in hepatocellular carcinoma: NSUN2-mediated increase of SOAT2 RNA methylation.肝细胞癌免疫逃逸的新型分子机制:NSUN2介导的SOAT2 RNA甲基化增加
Cancer Commun (Lond). 2025 Apr 14. doi: 10.1002/cac2.70023.
2
NSUN6 Maintains BMPER Stability in an m5C-Dependent Manner to Suppress Cell Proliferation and Migration in Hepatocellular Carcinoma.NSUN6以依赖于m5C的方式维持BMPER稳定性,从而抑制肝癌细胞的增殖和迁移。
Biol Cell. 2025 Jul;117(7):e70023. doi: 10.1111/boc.70023.
3
Mechanism of METTL14 regulates HBV-HCC malignant progression by mediating m6A modification of FOXP3 and thus transcriptional activation of ALDOB.METTL14通过介导FOXP3的m6A修饰从而激活ALDOB转录来调控HBV-HCC恶性进展的机制。
J Mol Histol. 2025 Aug 8;56(4):259. doi: 10.1007/s10735-025-10551-y.
4
NSUN2 knockdown ameliorates hepatic glucose and lipid metabolism disorders in type 2 diabetes mellitus through the Inhibition of ACSL6 m5C methylation.NSUN2基因敲低通过抑制ACSL6基因的m5C甲基化改善2型糖尿病的肝脏葡萄糖和脂质代谢紊乱。
Lipids Health Dis. 2025 Jul 10;24(1):236. doi: 10.1186/s12944-025-02652-0.
5
NSUN2-mediated RNA mC modification drives multiple myeloma progression by enhancing the stability of HIP1 mRNA.NSUN2介导的RNA mC修饰通过增强HIP1 mRNA的稳定性驱动多发性骨髓瘤进展。
Sci Rep. 2025 Jul 31;15(1):27888. doi: 10.1038/s41598-025-13695-9.
6
NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma.NSUN2 通过调控 m5C RNA 修饰依赖的 Wnt 信号通路促进肝癌进展。
Oncogene. 2024 Nov;43(47):3469-3482. doi: 10.1038/s41388-024-03184-0. Epub 2024 Oct 7.
7
The glucose sensor NSUN2-mC modification regulates tumor-immune glucose metabolism reprogramming to drive hepatocellular carcinoma evolution.葡萄糖传感器NSUN2-mC修饰调节肿瘤免疫葡萄糖代谢重编程以驱动肝细胞癌进展。
Int J Biol Sci. 2025 Jul 11;21(10):4529-4548. doi: 10.7150/ijbs.115610. eCollection 2025.
8
The impact of de novo lipogenesis on predicting survival and clinical therapy: an exploration based on a multigene prognostic model in hepatocellular carcinoma.从头脂肪生成对预测生存和临床治疗的影响:基于肝细胞癌多基因预后模型的探索
J Transl Med. 2025 Jun 18;23(1):679. doi: 10.1186/s12967-025-06704-y.
9
SNRPB/CCNB1 axis promotes hepatocellular carcinoma progression and cisplatin resistance through enhancing lipid metabolism reprogramming.SNRPB/CCNB1轴通过增强脂质代谢重编程促进肝细胞癌进展和顺铂耐药。
J Exp Clin Cancer Res. 2025 Jul 18;44(1):211. doi: 10.1186/s13046-025-03463-y.
10
Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1α axis in hepatocellular carcinoma.莲心碱通过激活腺苷酸活化蛋白激酶-低氧诱导因子-1α轴重编程代谢,重塑免疫微环境并增强肝细胞癌的免疫治疗效果。
J Exp Clin Cancer Res. 2025 Jul 15;44(1):208. doi: 10.1186/s13046-025-03477-6.

引用本文的文献

1
Epitranscriptomic mechanisms and implications of RNA mC modification in cancer.癌症中RNA mC修饰的表观转录组学机制及其影响
Theranostics. 2025 Jul 25;15(16):8404-8428. doi: 10.7150/thno.112332. eCollection 2025.
2
m5C RNA modification in colorectal cancer: mechanisms and therapeutic targets.结直肠癌中的m5C RNA修饰:机制与治疗靶点
J Transl Med. 2025 Aug 21;23(1):948. doi: 10.1186/s12967-025-06985-3.
3
A bibliometric analysis of immune escape in colorectal cancer: research trends, key contributors, and future directions.

本文引用的文献

1
Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma.肝细胞癌患者中固醇O-酰基转移酶1的综合预后及免疫分析
World J Hepatol. 2024 Mar 27;16(3):439-451. doi: 10.4254/wjh.v16.i3.439.
2
Crosstalk between endothelial progenitor cells and HCC through periostin/CCL2/CD36 supports formation of the pro-metastatic microenvironment in HCC.内皮祖细胞通过骨桥蛋白/CCL2/CD36 与 HCC 的串扰,支持 HCC 中促转移微环境的形成。
Oncogene. 2024 Mar;43(13):944-961. doi: 10.1038/s41388-024-02960-2. Epub 2024 Feb 13.
3
Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells.
结直肠癌免疫逃逸的文献计量分析:研究趋势、主要贡献者及未来方向。
Front Immunol. 2025 Jun 27;16:1614613. doi: 10.3389/fimmu.2025.1614613. eCollection 2025.
4
m5C RNA methylation in cancer: from biological mechanism to clinical perspectives.癌症中的m5C RNA甲基化:从生物学机制到临床视角
Eur J Med Res. 2025 Jun 21;30(1):503. doi: 10.1186/s40001-025-02812-z.
抑制内质网应激反应可通过改变肝癌细胞的脂质代谢来增强阿霉素的效果。
Mol Metab. 2024 Jan;79:101846. doi: 10.1016/j.molmet.2023.101846. Epub 2023 Nov 27.
4
Single-cell dissection of the multicellular ecosystem and molecular features underlying microvascular invasion in HCC.单细胞剖析多细胞生态系统和 HCC 微血管侵犯的分子特征。
Hepatology. 2024 Jun 1;79(6):1293-1309. doi: 10.1097/HEP.0000000000000673. Epub 2023 Nov 16.
5
Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review.揭示肿瘤浸润性T细胞和免疫疗法在肝细胞癌中的作用:一项综述
Cancers (Basel). 2023 Oct 19;15(20):5046. doi: 10.3390/cancers15205046.
6
Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma.内皮细胞二氢黄酮醇 4-还原酶促进肝细胞癌的肿瘤血管生成和免疫逃逸。
J Hepatol. 2024 Jan;80(1):82-98. doi: 10.1016/j.jhep.2023.10.006. Epub 2023 Oct 12.
7
Pyruvate kinase M2 regulates kidney fibrosis through pericyte glycolysis during the progression from acute kidney injury to chronic kidney disease.丙酮酸激酶 M2 通过急性肾损伤向慢性肾脏病进展过程中的周细胞糖酵解调节肾脏纤维化。
Cell Prolif. 2024 Feb;57(2):e13548. doi: 10.1111/cpr.13548. Epub 2023 Sep 25.
8
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.探讨肿瘤微环境中内皮细胞、免疫细胞和免疫检查点之间的串扰:新的见解和治疗意义。
Cell Death Dis. 2023 Sep 4;14(9):586. doi: 10.1038/s41419-023-06119-x.
9
miR-33a-3p regulates METTL3-mediated AREG stability and alters EMT to inhibit pancreatic cancer invasion and metastasis.miR-33a-3p 通过调控 METTL3 介导的 AREG 稳定性改变 EMT 抑制胰腺癌侵袭转移
Sci Rep. 2023 Aug 21;13(1):13587. doi: 10.1038/s41598-023-39506-7.
10
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.NSUN2 是一种葡萄糖传感器,可抑制 cGAS/STING 以维持肿瘤发生和免疫治疗抵抗。
Cell Metab. 2023 Oct 3;35(10):1782-1798.e8. doi: 10.1016/j.cmet.2023.07.009. Epub 2023 Aug 15.